Edgewise Therapeutics, Inc. (EWTX)
$36.28-5.64%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3.9B
- Beta
- 0.28
- P/E (TTM)
- -19.61
- Short % float
- 14.10%
- Days to cover
- 5.6
- SI change
- +17.6%
- 1W
- -9.35%
- 1M
- -18.69%
- vs SPY 1W
- -9.21%
- vs SPY 1M
- -21.20%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on EWTX?
- LOPJLB’s latest quantitative signal on Edgewise Therapeutics, Inc. (EWTX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is EWTX in?
- Edgewise Therapeutics, Inc. (EWTX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Edgewise Therapeutics, Inc. (EWTX) do?
- Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully …